BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18083920)

  • 1. Nephroblastoma overexpressed (Nov) is a novel bone morphogenetic protein antagonist.
    Canalis E
    Ann N Y Acad Sci; 2007 Nov; 1116():50-8. PubMed ID: 18083920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia.
    Rydziel S; Stadmeyer L; Zanotti S; Durant D; Smerdel-Ramoya A; Canalis E
    J Biol Chem; 2007 Jul; 282(27):19762-72. PubMed ID: 17500060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways.
    Minamizato T; Sakamoto K; Liu T; Kokubo H; Katsube K; Perbal B; Nakamura S; Yamaguchi A
    Biochem Biophys Res Commun; 2007 Mar; 354(2):567-73. PubMed ID: 17250806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of CCN genes in murine osteoblasts.
    Parisi MS; Gazzerro E; Rydziel S; Canalis E
    Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.
    Smerdel-Ramoya A; Zanotti S; Stadmeyer L; Durant D; Canalis E
    Endocrinology; 2008 Sep; 149(9):4374-81. PubMed ID: 18535099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis.
    Canalis E; Smerdel-Ramoya A; Durant D; Economides AN; Beamer WG; Zanotti S
    Endocrinology; 2010 Jan; 151(1):221-33. PubMed ID: 19934377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
    Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
    J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of connective tissue growth factor in skeletal growth and development.
    Kanaan RA; Aldwaik M; Al-Hanbali OA
    Med Sci Monit; 2006 Dec; 12(12):RA277-281. PubMed ID: 17136017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.
    Abreu JG; Ketpura NI; Reversade B; De Robertis EM
    Nat Cell Biol; 2002 Aug; 4(8):599-604. PubMed ID: 12134160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
    Yu C; Le AT; Yeger H; Perbal B; Alman BA
    J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation.
    Grotendorst GR; Duncan MR
    FASEB J; 2005 May; 19(7):729-38. PubMed ID: 15857887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
    Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.
    Luo Q; Kang Q; Si W; Jiang W; Park JK; Peng Y; Li X; Luu HH; Luo J; Montag AG; Haydon RC; He TC
    J Biol Chem; 2004 Dec; 279(53):55958-68. PubMed ID: 15496414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.
    Perbal B
    Mol Pathol; 2001 Apr; 54(2):57-79. PubMed ID: 11322167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connective tissue growth factor enhances osteoblastogenesis in vitro.
    Smerdel-Ramoya A; Zanotti S; Deregowski V; Canalis E
    J Biol Chem; 2008 Aug; 283(33):22690-9. PubMed ID: 18583340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis and therapeutic implication of the interaction of CCN proteins with glycoconjugates.
    Desnoyers L
    Curr Pharm Des; 2004; 10(31):3913-28. PubMed ID: 15579080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.
    Denton CP; Abraham DJ
    Curr Opin Rheumatol; 2001 Nov; 13(6):505-11. PubMed ID: 11698729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).
    Brigstock DR
    Angiogenesis; 2002; 5(3):153-65. PubMed ID: 12831056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
    Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
    J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.